Records containing: Hemophilia A
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-04-28A Multicenter, Open, Extension Trial to Evaluate Safety and Efficacy of Recombinant Human Coagulation Factor VIII (SCT800) During Long Term Treatment in Previously Treated Patients With Severe Haemophilia A .
-
CLINICAL_TRIALS study record update · 2020-04-07ClinicalTrials.gov study NCT00005304
-
CLINICAL_TRIALS study record update · 2020-03-16Interest of Preventive Personalized Treatment in Hemophilia A
-
CLINICAL_TRIALS study record update · 2020-03-11PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A
-
CLINICAL_TRIALS study record update · 2020-02-25Exercise Versus DDAVP in Patients With Mild Hemophilia A - is One Non-inferior to the Other and do They Work Additively in Improving Hemostasis?
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-02-13Ultrasonography in Hemophilic Joint Disease
-
CLINICAL_TRIALS study record update · 2020-02-06A Multicenter, Open, Single Arm Evaluation of the Efficacy, Safety and Pharmacokinetics of Recombinant Human Coagulation FVIII (SCT800) in Prophylaxis Therapy on Patients With Severe Hemophilia A Who Had Previously Treated With FVIII.
-
CLINICAL_TRIALS study record update · 2019-12-02A Phase 1/2a, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Previously Treated Adults With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2019-09-30A Single-Center, Open-Label, Single Dose Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers
-
CLINICAL_TRIALS study record update · 2019-09-09Single Dose, Open Label, Randomized, Crossover Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters of BAY 94 9027 and Elocta
-
CLINICAL_TRIALS study record update · 2019-08-26Phase 3, Prospective, Randomized, Multi-center Clinical Study Comparing the Safety and Efficacy of BAX 855 Following PK-guided Prophylaxis Targeting Two Different FVIII Trough Levels in Subjects With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2019-08-19Randomized, Open-label, Double Cycle, Crossover, Pharmacokinetics Study of Recombinant Coagulation Factor VIII Injection Versus Xyntha® in Subjects With Hemophilia A.
-
CLINICAL_TRIALS study record update · 2019-08-19Multicenter, Noncontrol Study of Recombinant Coagulation Factor VIII for Prophylactic Therapy in Subjects With Hemophilia A.
-
CLINICAL_TRIALS study record update · 2019-07-19AN OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF REFACTO AF IN PREVIOUSLY UNTREATED PATIENTS IN USUAL CARE SETTINGS
-
CLINICAL_TRIALS study record update · 2019-07-11Gait Evaluation in Haemophiliac Patients
-
CLINICAL_TRIALS study record update · 2019-05-20UNDERSTANDING HEMOPHILIA A AND B DRUG DOSAGE ADMINISTRATION PATTERNS
-
CLINICAL_TRIALS study record update · 2019-05-13A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (SCT800) in Previously Treated Paediatric Patients With Severe Haemophilia A.
-
CLINICAL_TRIALS study record update · 2019-05-03TREATMENT PATTERNS AND OUTCOMES IN PATIENTS TREATED WITH BENEFIX OR REFACTO/REFACTO AF - A SWEDISH COHORT STUDY
-
CLINICAL_TRIALS study record update · 2019-05-01A Phase 3b Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding in Previously Treated Patients With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2019-04-10A Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Administration of Emicizumab in Hemophilia A Pediatric Patients With Inhibitors
-
CLINICAL_TRIALS study record update · 2019-03-27A Prospective, International, Longitudinal, Observational Disease Registry of Patient-reported Outcomes (PROs) and the Association With Hemophilia A and Its Treatment in Patients With Moderate to Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2019-02-18Individualizing Hemophilia Prophylaxis Using Thromboelastography
-
CLINICAL_TRIALS study record update · 2019-01-29Calibrated Automated Thrombogram: A Scandinavian Multicenter Study
-
CLINICAL_TRIALS study record update · 2019-01-11An Open-label Study To Evaluate Prophylaxis Treatment, And To Characterize The Efficacy, Safety, And Pharmacokinetics Of B-domain Deleted Recombinant Factor Viii Albumin Free (Moroctocog Alfa [Af-cc]) In Children With Hemophilia A
-
CLINICAL_TRIALS study record update · 2018-12-26A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks (Q4W) in Patients With Hemophilia A